Categories Earnings, Retail

Ascena Retail Group (NASDAQ: ASNA): Q2 2020 Earnings Snapshot

— Ascena Retail Group Inc. (NASDAQ: ASNA) reported a second-quarter 2020 net loss of $97.4 million or $9.76 per share, wider than a loss of $71.5 million or $7.24 per share in the previous year quarter.

— Adjusted loss from continuing operations was $4.95 per share, which reflects the 1-for-20 reverse stock split that became effective during the second quarter.

Earnings Update by AlphaStreet

— Revenue declined by 4% to $1.22 billion versus $1.45 billion expected. This primarily reflects a comparable sales decrease of 2% for the quarter, a decline in other revenue and a decrease in non-comparable sales.

— During the quarter, Ascena incurred non-cash impairment charges of goodwill and other intangible assets. This offset in part by the benefit of cost reductions.

— At the end of the second quarter, the company had cash and cash equivalents of $374 million while the total debt stood at $1.29 billion, which represents the balance remaining on the term loan.

— Looking ahead into the third quarter, the company expects net sales in the range of $1.05-1.08 billion and comparable sales in the negative low-single digits range. The consensus estimates revenue of $1.3 billion.

— Gross margin is predicted to be in the range of 57.8-58.3% and adjusted operating loss is projected to be in the range of $30-10 million for the third quarter.

— For the full year, the company continues to expect the total capital spending to be in the range of $80-100 million, which represents a significant decrease compared to prior years.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top